Selective and potent peptide inhibitors of Kv1.3

Details for Australian Patent Application No. 2010226392 (hide)

Owner Amgen Inc.

Inventors Sullivan, John K.; Miranda, Leslie P.; Gegg, Colin V.; Hu, Shaw-Fen Sylvia; Belouski, Edward J.; Murray, Justin K.; Nguyen, Hung; Walker, Kenneth W.; Arora, Taruna; Jacobsen, Frederick W.; Li, Yue-Sheng; Boone, Thomas C.

Agent Shelston IP

Pub. Number AU-A-2010226392

PCT Pub. Number WO2010/108154

Priority 61/210,594 20.03.09 US

Filing date 19 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/108154 Priority application(s): WO2010/108154

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010226393-Modulators of cystic fibrosis transmembrane conductance regulator

2010226391-Carrier immunoglobulins and uses thereof